Expand employee base
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- 31 Dec 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Expand employee base from nearly 40 to approximately 150 by year-end 2021”
What we found
Evidence strength A What the grades mean
The company reported having 178 employees as of December 31, 2021, exceeding its target of approximately 150 employees.
-
A Taysha Gene Therapies, Inc. 10-K filed 2022-03-31
“As of December 31, 2021, we had 178 employees” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Rollout
- Indicative materiality
- Low rules
- Action
- Expand
- Deliverable
- employee base
- Target
- 150 employees
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Taysha Gene Therapies, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-TSHA-022713 · Corrections policy